21/09/2026
We are pleased to share an overview of the Renata PLC-sponsored randomized clinical study (NCT06531018) at Dhaka Medical College Hospital.
The study is evaluating eltrombopag 25 mg once daily with prednisolone versus matched placebo with prednisolone as first-line therapy in adults with newly diagnosed ITP.
Please note that the study results are pending, and no efficacy conclusion should be drawn before publication.
Kind regards,
Oncology & Haematology Team
Renata PLC